European Partnership with Recordati Established to Maximize VAZKEPA® in Europe; Global Corporate Restructuring Implemented with Anticipated $70 Million in Operating Expense Savings Over Next 12 Months ...

AngioDynamics, Inc. announced enrollment of the first patient in the AMBITION BTK study of the Auryon atherectomy system.

AngioDynamics (Nasdaq:ANGO) announced today that it enrolled the first patient in a randomized study of its Auryon ...

Five Dogs of the Dow stocks offer big yields, a degree of safety from tariffs, and a long history of corporate success.

Detailed price information for Angiodynamics Inc (ANGO-Q) from The Globe and Mail including charting and trades.

Impact of prognostic scores on acute kidney injury assessment in the postoperative period of myocardial revascularization ...

NEW YORK, NY, USA I July 24, 2025 I GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, today announced its IND ...

Coronary artery disease continues to be a prime public health concern worldwide, representing a leading cause of morbidity and mortality. Despite remarkable ...

Artery Type: The iliac artery segment accounts for a substantial 48% market share in 2025. However, the femoral-popliteal ...